Risks
4 risks
Risk Intelligence
EV demand timing uncertainty
View Risks →Gujarat Fluorochemicals Limited — Q4 FY25
GFL reported Q4 FY25 revenue of INR 1,225 crore (+8% YoY) and EBITDA of INR 305 crore (+28% YoY), with margins expanding 400 bps to 25%.
bullish
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GFL reported Q4 FY25 revenue of INR 1,225 crore (+8% YoY) and EBITDA of INR 305 crore (+28% YoY), with margins expanding 400 bps to 25%. PAT nearly doubled to INR 191 crore. Growth was driven by fluoropolymers volume and mix improvement, while bulk chemicals faced a plant incident and MDC price weakness. Management guided for ~25% fluoropolymer growth in FY26, R32 commissioning in H2 FY26, and EV battery revenue trickling in from H2 FY26. Key risks include EV demand timing and bulk chemical normalization. Net debt reduced to INR 1,451 crore.
जीएफएल ने वित्त वर्ष 2025 की चौथी तिमाही में 1,225 करोड़ रुपये की कमाई दर्ज की, जो पिछले साल से 8% अधिक है। कंपनी का परिचालन लाभ (EBITDA) 305 करोड़ रुपये रहा, जो 28% बढ़ा। मुनाफा लगभग दोगुना होकर 191 करोड़ रुपये हो गया। यह वृद्धि फ्लोरोपॉलीमर (एक खास तरह का प्लास्टिक) की बिक्री बढ़ने से हुई। हालांकि, बल्क केमिकल्स में एक प्लांट दुर्घटना और एमडीसी की कीमतों में गिरावट से असर पड़ा। कंपनी का कहना है कि अगले साल फ्लोरोपॉलीमर में 25% बढ़ोतरी होगी। आर32 (एक रेफ्रिजरेंट) का उत्पादन साल की दूसरी छमाही में शुरू होगा। ईवी बैटरी से कमाई भी उसी समय से आने लगेगी। जोखिमों में ईवी की मांग और केमिकल बाजार में सुधार शामिल है। कंपनी का कर्ज घटकर 1,451 करोड़ रुपये रह गया है।
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Fluoropolymer Revenue Growth
~25%
+25% YoY
Management expects ~25% growth in fluoropolymers in FY26 driven by new fluoropolymers and legacy player exits.
Net Debt
INR 1,451 crore
-INR 318 crore YoY
Net debt reduced from INR 1,769 crore as of March 2024, improving net debt-to-equity from 0.3 to 0.2.
CapEx for FY26
INR 1,600 crore
+INR 900 crore YoY
CapEx of INR 1,600 crore planned for FY26, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.
R32 Capacity Target
20,000 tonnes
New capacity
Management targets 20,000 tonnes R32 capacity, with commissioning expected in H2 FY26 via retrofitting and new builds.
What Changed vs Last Quarter
NEW
Fluoropolymer growth of ~25% in FY26
Management expects ~25% year-on-year growth in fluoropolymers revenue, driven by new fluoropolymers and legacy player exits.
NEW
R32 commissioning in H2 FY26
R32 plant expected to commence commercial sales in the second half of FY26, with a target capacity of 20,000 tonnes.
NEW
EV battery revenue trickling in from H2 FY26
Revenue from EV battery materials (LiPF6, LFP, binders, electrolytes) expected to start in H2 FY26, with ramp-up in FY27.
NEW
CapEx of INR 1,600 crore for FY26
Planned CapEx of INR 1,600 crore, with INR 1,200 crore for EV battery materials and INR 400 crore for fluoropolymers and refrigerants.
DROPPED
Fluoropolymer full capacity utilization by end-FY26
Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and market demand.
DROPPED
R32 capacity of 30,000 tons with first phase of 20,000 tons by Q4 FY26
GFL plans to set up 30,000 tons of R32 capacity in phases, with the first phase of 20,000 tons expected to be operational by Q4 FY26, at a CapEx of around INR 150 crores.
DROPPED
EV battery materials cumulative CapEx of INR 6,000 crores by FY28
GFL remains committed to its cumulative CapEx plan of INR 6,000 crores by FY28 for the EV battery materials business, targeting ~2x asset turnover and ~25% EBITDA margins at optimal utilization.
DROPPED
Power cost savings of ~INR 150 crores annually from FY26
Through renewable energy PPAs, GFL expects annual power cost savings of approximately INR 150 crores, reducing the weighted average power cost to around INR 4.5 per unit.
NEW RISK
EV demand timing uncertainty
Revenue from EV battery materials may be delayed if customer qualifications or market ramp-up take longer than expected.
NEW RISK
Bulk chemical segment recovery
The CMS-1 plant incident caused ~15% production loss, and MDC price declines may persist, impacting profitability.
NEW RISK
Working capital build-up
Working capital days increased due to inventory build-up for anticipated demand; normalization may take 1-2 quarters.
NEW RISK
Competitive pricing pressure from China
Battery material prices in China have dropped significantly, potentially limiting pricing premium for non-Chinese suppliers.
RISK GONE
R32 pricing volatility could impact CapEx decision
The decision to invest in R32 capacity is based on current pricing and demand-supply dynamics; a reversal in pricing could affect the viability of the investment.
RISK GONE
Potential revocation of IRA subsidies in the US
Changes in US policy, such as revocation of IRA subsidies, could impact the EV battery materials business, though management believes customer plans remain intact.
RISK GONE
Delays in domestic EV battery material ramp-up
The electrolyte business for the domestic market is experiencing hiccups as customers' plants face startup delays, which could slow revenue contributions.
RISK GONE
Chinese competition in fluoropolymers and refrigerants
Commodity-grade PTFE continues to face pricing pressure from low-cost Chinese suppliers, and additional MDC capacity in India could keep prices muted.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management revised FY25 EBITDA guidance from 'better than FY23' to 'at par with FY23', indicating slower recovery.
Mentioned in Q1 FY25, Q2 FY25, Q3 FY25
Commodity-grade PTFE continues to face pricing pressure from low-cost Chinese suppliers, and additional MDC capacity in India could keep prices muted.
Mentioned in Q1 FY25, Q2 FY24, Q2 FY25
While management downplays the impact, evolving PFAS regulations globally could affect fluoropolymer demand or increase compliance costs.
Mentioned in Q1 FY24, Q3 FY24
Legacy player inventory may take longer to deplete than expected, delaying volume recovery.
Mentioned in Q1 FY25, Q3 FY25
Management expects to achieve full capacity utilization in the fluoropolymer segment by the end of FY26, driven by new product qualifications and market demand.
Fast read
Guidance and risk preview
Management expects ~25% year-on-year growth in fluoropolymers revenue, driven by new fluoropolymers and legacy player exits.
Revenue from EV battery materials may be delayed if customer qualifications or market ramp-up take longer than expected.
View Risks →